XOMA Corp

NASDAQ XOMAP

Download Data

XOMA Corp Cash Return on Equity (CROE) 1 year YoY Change (%) for the quarter ending March 31, 2024: -56.15%

XOMA Corp Cash Return on Equity (CROE) 1 year YoY Change (%) is -56.15% for the quarter ending March 31, 2024. The cash return on equity ratio measures the profitability of a company's shareholders' equity based on its operating cash flow. It is calculated by dividing operating cash flow by shareholders' equity. This ratio provides insight into how effectively the company generates cash flow in relation to the shareholders' investment. A higher ratio indicates better cash flow generation relative to the equity invested. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • XOMA Corp Cash Return on Equity (CROE) for the quarter ending March 31, 2023 was -0.04.
NASDAQ: XOMAP

XOMA Corp

CEO -
IPO Date Dec. 16, 2020
Location United States
Headquarters 2200 Powell Street, EmeryVille, CA, United States, 94608
Employees 13
Sector Healthcare
Industry Biotechnology
Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

XOMAO

XOMA Corporation

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email